
Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan
Alvotech and Dr. Reddy's to Partner on Pembrolizumab Alvotech and Dr. Reddy’s Laboratories have announced a strategic partnership to co-develop, manufacture, and commercialize a biosimilar candidate referencing Keytruda (pembrolizumab), one of the …